Login

Johan Ek, CEO, Handicare Group 00:00:00

Share On Facebook Share On Twitter

Handicare - Interview with CEO Johan Ek

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Ausgold: Kittanning Gold Project Overview
00:10:00
F&C Investment Trust | Insights from Tom Joy, Independent Non-Executive Director
00:10:00
Shanta Gold: Focused on Operational Excellence and Strategic Growth in Tanzania
00:10:00
The GO Foundation South Australia launches on Friday, February 15, at the Adelaide Fringe Festival along the Torrens River.
00:10:00
"From Tax Law to Real Estate: A Decade of Opportunity with Bridge Investment Group"|CFO,Bridge Investment Group Holdings Inc
00:10:00
Natural Law and American Constitutionalism: Insights from Hadley Arkes|Hadley Arkes
00:10:00
PT M Cash Integrasi Tbk (MCAS) plans to enter the digital restaurant service business, having begun trials since the beginning of the year.
00:10:00
Caverion's Operational Performance Strengthened Towards Year-End: CEO Comments on inderesTV | Jacob Götzsche - CEO of Caverion
00:10:00
The Foundation of Successful Investing: Insights from Allodium Investment Consultants | David J. Bromelkamp - CEO of Allodium Investment Consultants
00:10:00
Support the next-rising technologies, products, and services that delight consumers|Richard Jun,Managing Partner,BAM Ventures
00:10:00
Acast ceo Ross Adams interviewed by Nyhetsbyrån Direkt | Ross Adams, CEO, Acast AB (publ)ACAST:STO
00:10:00
Benefits of Incorporating: Asset Protection, Tax Flexibility, and Perpetual Existence

© 2026 Nehu